Wednesday, February 6, 2013

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Feb 6)
• Unmet Medical Need in Treatment of Heart Failure Patients with Atrial Fibrillation Highlighted in Articles in Inaugural Issue of JACC: Heart FailureBusiness Wire (Wed, Feb 6)

Monday, February 4, 2013

• Arca Biopharma Rallies On New Plans For A Phase III Trialat Seeking Alpha (Mon, Feb 4)

Friday, February 1, 2013

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitEDGAR Online (Fri, Feb 1)
• Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost RevenuesMarketwired (Fri, Feb 1)

Wednesday, January 30, 2013

• 4 Healthcare Stock Stories for Wednesday Wellnessat Wall St. Cheat Sheet (Wed, Jan 30)
• ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 30)

Tuesday, January 29, 2013

• New Adaptive Phase 3 Trial Planned for GencaroTM in Atrial FibrillationBusiness Wire (Tue, Jan 29)

Wednesday, January 23, 2013

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuEDGAR Online (Wed, Jan 23)

Thursday, January 3, 2013

• GencaroTM Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and ElectrophysiologyBusiness Wire (Thu, Jan 3)
• ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 3)

Wednesday, December 19, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuEDGAR Online (Wed, Dec 19)

Wednesday, December 12, 2012

• CORRECTING AND REPLACING GencaroTM Cardiovascular Effect on Patients with Atrial Fibrillation Paper Published in European Journal of Heart FailureBusiness Wire (Wed, Dec 12)
• ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Dec 12)

Tuesday, November 13, 2012

• ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 13)

Tuesday, October 23, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuEDGAR Online (Tue, Oct 23)

Tuesday, October 16, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandaEDGAR Online (Tue, Oct 16)

Friday, August 17, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online (Fri, Aug 17)

Thursday, August 16, 2012

• 5 Biotech Stocks Under $5 Blasting Offat TheStreet (Thu, Aug 16)

Monday, August 13, 2012

• ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Aug 13)

Friday, August 3, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitEDGAR Online (Fri, Aug 3)

Wednesday, May 30, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online (Wed, May 30)

Monday, May 14, 2012

• ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, May 14)

Monday, April 16, 2012

• ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandaEDGAR Online (Mon, Apr 16)

Add ABIO News to My Yahoo!